AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
AI Test for Bladder Cancer Gets FDA Breakthrough Designation, Boosting Momentum in Urologic Diagnostics
An AI test for bladder cancer has received FDA Breakthrough Device Designation, a status that can speed development and review for promising technologies. The designation adds to a wave of regulatory momentum around AI-powered diagnostics, especially in oncology and risk stratification.
Valar Labs Wins FDA Breakthrough Nod for Vesta Bladder Risk Stratify Dx
Valar Labs has received FDA Breakthrough Device Designation for its Vesta Bladder Risk Stratify Dx test, signaling confidence in AI-driven bladder cancer risk assessment. The recognition reinforces a broader trend: regulators are increasingly engaging with narrow, clinically grounded AI diagnostics rather than generalized medical AI claims.
Breakthrough Designation for AI-Guided Memory Implant Shows Neurotech’s Regulatory Momentum
Nia Therapeutics has received FDA Breakthrough Device designation for an AI-guided brain implant intended to treat memory loss. The designation spotlights a fast-emerging intersection of neurostimulation, closed-loop algorithms, and precision neurology.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.